Using different cell-type-specific promoters, the transgenes can be expressed in different cells (e.g., Thy1 promoters for neurons, Gfap for astrocytes [58]), allowing for a better mechanistic approach to the understanding of how expression of AD-associated genes affects each cell type, and as a result determination of their contribution to AD pathogenesis. The gene discussed is GFAP; the disease is Alzheimer disease.